rfhg_43269.1

Basic information about the TSS

---

TSS ID: rfhg_43269.1 TSS ID(Version3): hg_35728.1 hg_35727.1 hg_35729.1 Species: human Chr: chr3		Start: 23917084 End: 23917211 Strand: +
Source datasets	FANTOM5|ENCODE|PRJNA401781|DRA013844|PRJDB5282|PRJNA4843412 |PRJNA615891|PRJNA548673|PRJNA597322
Protocol	CAGE|oligo_capping|C1CAGE|NETCAGE|SLIC_CAGE|RAMPAGE |ReCappable-seq|STRIPE-seq|TIF-seq2
TSS cluster detected*	13

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3403813,EH38E2185600)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000307839.10:0 ENST00000413699.7:0 ENST00000645079.1:0 ENST00000456530.7:0 ENST00000412097.5:0 ENST00000644684.1:0 ENST00000415719.5:0 ENST00000490223.1:0 ENST00000644185.1:0 ENST00000465786.1:0 ENST00000436146.2:0 BC081565:0 BC014837:0 AK129815:0 AK091751:0 BX537495:0 BC070328:0 AK290694:0 AK292000:0 AK297091:0 AF283772:0 BC068198:0 AK293709:0 AK098795:0 BC071672:0 AF279903:0 GeneID: 6138 HGNC/MGI_ID: HGNC:10306 UniProt_ID: A0A024R2Q4 A0A2R8YEM3 B4DEN1 B4DLP4 E7ENU7 E7ERA2 P61313 Nearer transcript ids and distances: ENST00000643707.1:88 ENST00000434031.6:-105 ENST00000611050.4:-280 ENST00000422218.5:-493 ENST00000354811.5:494 view more...

Gene_name: ribosomal protein L15 Gene_symbol: RPL15 Gene_synonyms: EC45 L15 RPL10 RPLY10 RPYL10 Gene_source: HGNC:10306

TATA-Box annotation

---

Distance to TSS:	15
Nearest PromoterID:	NM_001253383
Entrez ID:	6138
Nearest Unigene:	Hs.381219
Nearest Refseq:	NM_002948
Nearest Ensembl:	ENSG00000174748
Gene Name:	ribosomal protein L15
Gene Alias:	DBA12|EC45|L15|RPL10|RPLY10|RPYL10
Gene Type:	protein-coding
CpG%:	0.039370
GC%:	0.585938
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL15 p2@RPL15 p3@RPL15 p4@RPL15
Sample		p1@RPL15	p2@RPL15	p3@RPL15	p4@RPL15
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	205.13	61.36	34.48	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	216.08	65.75	38.64	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	225.50	70.80	32.79	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	175.89	55.93	35.76	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	184.92	62.54	36.44	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	196.72	77.52	38.57	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	309.39	97.83	47.06	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	276.86	64.91	44.57	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	304.97	69.46	44.88	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	165.19	73.61	29.56	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	132.99	67.91	36.38	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	125.62	60.98	31.71	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	47.23	58.51	5.96	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	51.72	60.59	6.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	48.74	50.94	5.49	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	50.05	58.09	5.53	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	51.98	59.84	6.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.10	67.49	4.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	46.92	55.98	5.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.02	65.59	4.66	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	56.94	68.03	5.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	65.77	66.63	5.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	55.06	60.10	5.95	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	55.81	62.85	5.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	59.34	66.30	5.42	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	68.37	63.62	6.01	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	59.89	64.84	9.34	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	79.92	60.12	7.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	75.43	64.61	6.14	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	66.60	56.46	6.70	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	71.60	55.27	5.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	64.48	57.25	5.86	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	74.28	71.33	9.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	97.15	84.61	7.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	62.45	52.17	6.92	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	64.58	53.85	6.90	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	69.90	61.11	7.77	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	73.34	58.83	7.25	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	80.76	53.48	7.83	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	67.94	43.93	7.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	67.99	53.40	6.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	81.10	68.81	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	63.90	50.40	4.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	70.11	54.72	7.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	65.45	44.97	5.82	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	61.88	49.55	4.42	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	56.86	44.14	7.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	73.92	50.07	4.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	69.18	51.47	5.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	62.28	49.34	7.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	50.42	51.44	6.76	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.26	61.82	8.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	69.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	53.94	42.58	9.94	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	55.01	46.73	9.61	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	76.34	63.76	11.75	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	62.00	56.49	6.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	44.40	43.75	5.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	46.89	44.00	4.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	56.89	59.41	6.29	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	37.37	5.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.11	43.74	9.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	33.44	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	50.97	46.55	7.47	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.07	44.51	4.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.53	30.88	4.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	64.66	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	71.08	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	44.85	36.08	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	48.60	35.21	5.95	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	64.27	36.59	8.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.32	37.76	5.30	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	47.33	34.34	4.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	61.15	34.55	4.59	0.00
Adipocyte - breast, donor1	11376-118A8	58.29	52.43	10.93	0.16
Adipocyte - breast, donor2	11327-117E4	51.66	29.52	5.78	0.32
Adipocyte - omental, donor1	11473-119C6	62.21	47.84	8.78	0.38
Adipocyte - omental, donor2	11474-119C7	79.98	16.44	7.47	0.00
Adipocyte - omental, donor3	11475-119C8	58.28	18.76	4.02	0.33
Adipocyte - perirenal, donor1	11476-119C9	79.11	29.35	14.67	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	61.57	37.38	9.90	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	110.65	38.39	16.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	63.95	66.21	5.39	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	62.00	48.11	7.82	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	35.52	28.57	3.86	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	51.85	37.91	5.30	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	25.86	29.39	3.53	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	79.39	36.44	6.03	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	35.18	20.01	2.58	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	37.32	23.46	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	32.27	27.27	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	57.81	20.79	3.33	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	41.44	19.59	3.52	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	34.69	15.05	4.91	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	28.01	11.27	3.65	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	274.26	58.56	25.41	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	386.55	49.84	22.23	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	75.47	37.14	4.79	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	111.00	60.45	13.13	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	43.51	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	84.64	47.05	10.27	0.00
Anulus Pulposus Cell, donor1	11248-116E6	74.15	94.52	6.18	0.00
Anulus Pulposus Cell, donor2	11463-119B5	67.59	37.23	3.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	74.58	27.41	10.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	82.05	34.30	9.55	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	25.68	12.84	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	94.46	29.29	8.37	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	91.05	22.76	8.85	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	49.51	42.90	9.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	85.77	27.62	9.75	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	100.49	33.50	7.77	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	46.92	48.10	11.28	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	82.86	33.90	7.53	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	72.57	31.93	6.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	53.91	62.69	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	83.52	57.82	11.20	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	64.15	51.86	12.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	94.70	54.44	14.63	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	80.90	39.11	9.64	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	97.68	40.62	10.77	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	66.29	53.72	11.49	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	55.60	38.04	13.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	105.15	45.45	9.45	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	51.63	50.43	19.21	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	28.32	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	102.06	37.22	9.26	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	54.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	85.43	29.61	12.14	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	110.04	42.88	11.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	47.24	43.61	13.33	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	74.10	30.21	10.26	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	94.06	41.90	10.69	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	56.52	46.46	10.84	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	85.86	32.84	6.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	89.71	42.44	9.97	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	57.08	53.51	9.99	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	93.01	33.93	5.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	78.88	36.73	11.44	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	49.90	48.71	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	96.12	33.06	9.15	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	82.26	42.53	8.91	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.82	52.10	12.07	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	67.32	29.78	10.36	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	107.11	44.03	9.95	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.29	52.78	8.41	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	70.86	32.12	5.67	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	103.75	40.86	9.15	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	53.28	9.27	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	48.59	50.70	12.68	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	98.20	34.95	10.29	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	55.95	50.54	9.02	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	73.63	27.70	10.93	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	108.04	47.13	10.34	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	51.01	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	72.96	52.88	13.73	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	97.03	47.89	11.15	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	59.36	51.41	11.63	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	97.51	34.42	9.56	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	90.03	42.13	9.76	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	45.77	64.08	16.78	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	96.38	39.88	9.42	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	87.38	39.98	12.71	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	62.51	53.79	11.27	0.00
Astrocyte - cerebellum, donor1	11500-119F6	179.43	66.93	14.62	0.25
Astrocyte - cerebellum, donor2	11580-120F5	207.45	58.02	10.10	0.17
Astrocyte - cerebellum, donor3	11661-122F5	71.52	89.35	7.13	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	150.24	96.21	13.59	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	152.55	68.11	11.97	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	124.55	61.16	9.55	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	183.96	119.50	12.16	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	210.85	114.63	12.03	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	187.20	104.92	12.97	0.57
Basophils, donor1	12241-129G9	45.77	85.52	2.35	0.52
Basophils, donor2	12242-129H1	45.10	126.64	2.53	1.44
Basophils, donor3	12243-129H2	53.65	81.14	1.76	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	115.56	44.85	8.19	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	126.18	28.35	6.40	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	43.04	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	236.00	23.22	16.32	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	222.92	36.60	9.77	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	131.96	32.47	9.90	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	86.91	33.65	6.30	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	171.07	220.74	21.64	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	190.98	195.87	15.14	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	149.33	346.96	13.11	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	475.73	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	40.58	85.66	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	25.24	73.87	0.93	0.37
CD14+ Monocytes, donor3	11381-118B4	30.74	75.52	1.76	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.44	67.65	2.83	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.70	59.89	2.27	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	55.56	55.89	2.96	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	24.28	65.05	2.89	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	22.63	41.64	2.11	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	23.22	44.30	1.18	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.57	46.87	1.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.46	36.71	1.93	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.02	40.91	1.98	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.54	56.39	1.37	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	24.04	47.54	1.25	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	44.18	75.08	4.13	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	18.26	55.02	0.94	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.71	38.02	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	26.62	61.01	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	20.08	58.16	2.08	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.15	45.10	2.99	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.40	72.87	3.96	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	21.51	60.86	1.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.70	50.67	1.58	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	47.14	2.18	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	19.10	41.96	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	26.52	56.87	2.62	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.19	55.13	2.52	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.92	57.69	1.65	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.43	33.82	3.17	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	22.37	35.10	3.51	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.53	43.77	2.27	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.58	39.03	2.60	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.72	83.63	2.80	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	53.23	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.24	44.74	1.85	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.93	65.65	3.94	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	47.30	81.30	3.92	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	57.75	97.48	3.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	65.20	82.96	4.33	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	59.02	117.41	2.96	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	52.57	98.85	2.79	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	24.08	57.75	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	71.45	124.27	3.57	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	60.60	97.93	3.29	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	61.69	86.11	2.53	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	323.14	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	53.56	290.85	5.42	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	45.57	331.39	9.32	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	83.15	426.96	5.33	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	60.58	330.75	7.50	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	55.45	289.20	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.06	301.98	3.92	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	362.53	7.91	1.32
CD19+ B Cells, donor1	11544-120B5	47.67	170.13	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	33.37	117.52	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	38.37	126.71	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	117.18	73.13	4.85	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	109.86	73.11	7.59	0.00
CD34+ Progenitors, donor1	11545-120B6	31.13	241.98	5.02	3.01
CD34+ Progenitors, donor2	11625-122B5	39.33	133.15	6.74	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	192.39	224.33	12.78	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	195.95	283.43	14.88	1.35
CD4+ T Cells, donor1	11225-116C1	43.92	287.07	2.86	0.36
CD4+ T Cells, donor2	11306-117C1	27.56	284.14	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	40.26	205.57	2.44	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	50.54	83.46	3.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	62.21	116.57	2.92	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	48.29	107.80	2.01	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	67.32	383.54	4.74	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	72.34	460.72	2.81	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	253.81	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	54.48	79.92	2.02	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	58.13	85.75	3.05	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.30	80.28	2.26	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	56.04	169.01	4.93	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	61.49	191.46	4.54	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	38.28	133.31	2.64	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.89	84.33	2.95	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	49.66	85.81	3.12	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	32.08	87.54	2.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	32.63	303.21	4.89	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	48.24	292.63	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	150.63	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	57.67	92.16	5.75	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.22	81.01	1.95	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	52.12	82.17	1.89	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	72.30	275.55	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.99	285.51	3.90	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	41.40	164.30	2.61	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.84	357.79	4.95	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	59.08	300.96	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	348.96	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.40	166.71	1.94	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	65.76	154.60	2.94	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	317.24	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.03	275.03	4.66	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	304.70	8.31	1.38
CD8+ T Cells, donor1	11226-116C2	45.84	240.31	3.27	1.96
CD8+ T Cells, donor2	11307-117C2	31.16	192.97	2.25	1.88
CD8+ T Cells, donor3	11383-118B6	36.11	248.20	3.79	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	105.06	30.05	6.42	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	100.65	37.38	5.75	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	87.82	43.50	4.10	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	178.33	43.23	7.21	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	106.79	37.68	5.28	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	105.51	37.52	5.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	170.35	37.81	7.82	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	145.29	46.06	6.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	144.23	31.19	5.86	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	183.54	42.26	9.96	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	143.22	53.74	7.55	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	174.78	47.16	7.46	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	50.34	28.45	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	45.09	28.69	4.55	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	33.56	15.66	3.73	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	88.24	36.74	5.04	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	99.55	41.43	4.89	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	80.14	37.71	4.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	157.82	30.11	6.97	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	152.55	35.37	8.61	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	134.97	33.66	6.41	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	152.22	41.31	6.88	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	139.91	37.05	5.52	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	98.33	40.85	10.59	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	55.40	32.12	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	53.86	53.16	4.20	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	54.09	34.06	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	10.97	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	106.23	51.39	9.88	0.00
Cardiac Myocyte, donor3	11686-122I3	168.58	108.92	14.94	0.11
Chondrocyte - de diff, donor1	11261-116G1	110.24	33.63	7.63	0.00
Chondrocyte - de diff, donor2	11338-117F6	53.31	36.96	8.53	0.00
Chondrocyte - de diff, donor3	11410-118E6	49.61	55.75	6.37	0.00
Chondrocyte - re diff, donor2	11339-117F7	105.64	49.24	13.43	0.00
Chondrocyte - re diff, donor3	11411-118E7	30.33	51.76	4.85	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	127.73	119.12	12.51	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	100.90	76.10	11.97	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	112.04	74.43	10.89	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	75.10	91.43	3.30	26.87
Corneal Epithelial Cells, donor1	11526-119I5	183.12	51.38	12.74	0.22
Corneal Epithelial Cells, donor2	11606-120I4	96.70	27.30	13.65	0.00
Corneal Epithelial Cells, donor3	11687-122I4	191.21	55.22	16.87	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	26.91	18.33	1.98	7.10
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.12	24.92	1.26	7.57
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	17.25	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	33.37	16.74	1.51	3.78
Dendritic Cells - plasmacytoid, donor1	11228-116C4	82.68	168.77	1.71	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	55.49	210.88	2.61	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	81.30	98.72	2.90	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	157.43	58.87	9.51	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	138.48	36.38	5.28	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	104.35	44.40	9.33	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	78.64	42.46	9.44	0.39
Endothelial Cells - Artery, donor1	11264-116G4	131.47	45.96	9.31	0.58
Endothelial Cells - Artery, donor2	11341-117F9	164.69	63.05	12.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	195.12	45.76	12.97	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.49	63.84	7.54	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	44.42	43.81	5.17	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	43.13	43.13	4.51	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	100.13	44.57	7.13	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	155.68	42.17	10.93	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	51.61	74.72	3.26	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	186.86	48.41	11.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	92.77	33.02	8.39	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	176.80	110.58	16.03	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	79.08	46.93	6.08	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	107.59	45.19	8.30	0.37
Endothelial Cells - Vein, donor1	11267-116G7	145.60	50.05	17.06	0.00
Endothelial Cells - Vein, donor2	11344-117G3	99.19	37.72	10.48	0.70
Endothelial Cells - Vein, donor3	11416-118F3	150.10	75.05	9.42	0.31
Eosinophils, donor1	12244-129H3	45.74	152.47	0.00	0.00
Eosinophils, donor2	12245-129H4	33.01	72.61	1.65	0.00
Eosinophils, donor3	12246-129H5	24.97	32.10	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	121.67	38.11	8.55	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	112.33	22.88	12.48	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	48.81	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.75	32.43	4.93	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	82.77	22.88	11.61	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	121.45	62.84	12.78	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	161.18	77.26	21.10	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	105.90	36.44	14.19	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	73.51	41.98	6.54	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	70.35	14.49	7.38	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	113.61	52.49	10.63	0.00
Fibroblast - Cardiac, donor1	11268-116G8	133.37	47.63	13.16	0.00
Fibroblast - Cardiac, donor2	11345-117G4	68.22	56.85	10.61	0.00
Fibroblast - Cardiac, donor3	11417-118F4	89.74	44.48	10.09	0.16
Fibroblast - Cardiac, donor4	11452-119A3	73.96	53.65	11.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	133.12	43.27	9.01	0.13
Fibroblast - Cardiac, donor6	11460-119B2	161.14	48.66	13.34	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	85.49	36.58	6.70	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	66.44	43.14	3.88	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	177.24	51.27	14.65	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	245.86	107.02	20.99	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	35.79	96.50	4.24	0.00
Fibroblast - Dermal, donor1	11269-116G9	153.55	36.86	10.57	0.23
Fibroblast - Dermal, donor2	11346-117G5	167.92	39.15	11.79	0.00
Fibroblast - Dermal, donor3	11418-118F5	115.93	65.40	7.62	0.00
Fibroblast - Dermal, donor4	11450-119A1	232.42	60.82	9.72	0.23
Fibroblast - Dermal, donor5	11454-119A5	292.56	60.36	12.39	0.35
Fibroblast - Dermal, donor6	11458-119A9	291.71	60.75	12.99	0.32
Fibroblast - Gingival, donor1	11237-116D4	144.51	65.38	12.08	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	67.33	38.25	6.03	0.00
Fibroblast - Gingival, donor2	11318-117D4	169.21	82.76	10.67	0.00
Fibroblast - Gingival, donor3	11394-118C8	67.20	47.09	3.67	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	49.87	35.32	8.31	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.71	37.88	4.23	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	145.92	67.81	7.79	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	105.75	56.25	6.63	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.70	20.47	1.76	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	94.18	55.13	7.60	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	95.04	54.13	7.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	132.40	43.88	10.75	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.14	60.02	5.87	0.15
Fibroblast - Lung, donor1	11270-116H1	106.03	20.39	4.08	0.00
Fibroblast - Lung, donor2	11347-117G6	98.48	49.24	7.46	1.49
Fibroblast - Lung, donor3	11419-118F6	130.00	75.76	5.91	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	144.95	39.15	13.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	102.10	20.98	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	52.34	31.35	4.48	0.28
Fibroblast - Mammary, donor1	11540-120B1	188.78	60.90	14.21	0.00
Fibroblast - Mammary, donor2	11620-122A9	163.76	59.91	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	217.25	107.27	10.28	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	180.65	75.84	6.22	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	150.24	36.11	11.93	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	52.28	23.28	4.96	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	108.27	60.75	7.29	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	34.56	32.94	3.13	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	241.07	81.46	24.21	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	155.44	60.55	9.55	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	147.00	63.48	14.03	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	126.91	72.75	7.91	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	82.95	23.22	6.35	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	58.61	64.30	5.86	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	71.15	92.83	9.85	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	109.51	21.36	7.52	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	91.22	38.97	8.74	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	87.56	20.50	7.59	0.00
Fibroblast - skin normal, donor1	11553-120C5	85.32	51.85	6.73	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	97.05	47.72	8.82	0.40
Fibroblast - skin normal, donor2	11561-120D4	125.48	41.89	8.94	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	114.25	39.29	9.07	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	58.24	101.24	10.36	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	64.45	55.39	5.98	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	72.58	8.54	5.58	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	134.43	34.94	9.16	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	154.85	59.88	9.95	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	109.77	58.18	5.80	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	642.63	22.16	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	35.73	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	102.11	41.95	11.44	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	117.89	39.30	12.49	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	92.50	29.13	14.05	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	281.72	169.19	42.11	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	380.93	202.27	55.51	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	354.30	195.12	37.37	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	101.20	178.14	6.07	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	78.77	99.55	8.22	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	249.05	146.81	21.60	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.07	177.90	8.72	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	58.05	78.60	8.15	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	221.11	168.04	30.07	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	125.21	131.57	12.86	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	109.60	88.54	8.37	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	177.56	126.79	16.12	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	93.79	88.83	7.19	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	96.21	98.01	8.58	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	123.40	94.54	10.78	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	91.73	95.38	9.13	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	71.75	90.56	5.11	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	73.44	74.32	5.90	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	88.05	108.44	7.09	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	55.64	86.79	5.25	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	86.91	78.42	6.26	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	70.37	104.65	4.64	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	61.92	83.80	7.80	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	95.06	103.75	10.02	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.63	121.75	6.45	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.97	85.73	5.12	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	62.74	85.87	6.09	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	83.70	113.65	9.48	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	78.20	93.92	11.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	72.83	105.22	5.78	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	45.43	92.23	4.15	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	79.05	79.88	4.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.56	88.83	4.19	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	59.41	99.99	4.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	71.16	77.16	8.43	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.28	95.57	3.85	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	53.63	70.40	3.88	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	72.29	78.46	6.17	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	64.16	85.14	5.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	60.95	70.15	6.69	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.16	73.11	7.03	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	64.53	76.59	7.01	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.98	39.07	4.17	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	78.35	53.21	8.02	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	80.48	56.76	9.33	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	70.34	52.07	8.16	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	62.08	55.03	6.51	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	64.15	67.47	7.01	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	48.69	76.32	5.26	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	33.72	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	59.49	63.19	5.54	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	55.08	69.40	7.47	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.31	52.87	1.78	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	266.94	106.30	21.70	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	147.45	112.78	10.94	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	130.52	155.07	17.39	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	368.63	251.28	41.31	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	384.56	261.36	54.53	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	161.42	136.98	35.97	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	188.08	143.54	44.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	225.90	165.94	37.52	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	259.92	243.88	32.09	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	119.98	106.07	20.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	177.39	146.14	27.67	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	141.66	137.54	22.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	93.30	19.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	149.61	135.07	22.93	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	123.22	134.01	26.47	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	120.79	108.21	9.23	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	141.22	151.08	15.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	124.32	149.45	23.10	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	181.67	164.96	14.62	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	126.57	181.55	16.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	125.20	128.46	15.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	144.00	106.73	22.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	155.74	140.42	27.34	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	144.52	134.40	23.93	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	142.25	105.37	26.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	82.26	118.01	11.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	109.85	140.82	17.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	126.41	121.06	7.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	104.41	175.68	11.17	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	112.29	114.00	16.09	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	79.51	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.02	150.52	3.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	92.94	152.68	6.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	99.19	124.63	7.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	100.91	155.95	11.17	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	83.87	134.19	4.93	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	94.44	12.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	78.18	163.36	7.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.47	132.98	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	39.84	96.64	5.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	81.78	101.48	13.73	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	83.95	108.70	17.47	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	138.10	41.09	12.55	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	56.55	38.67	7.07	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	148.43	46.10	9.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	55.82	42.18	7.29	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	70.60	48.46	9.19	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	174.88	56.86	9.40	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	147.19	54.52	9.62	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	153.34	47.32	11.60	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	172.27	63.29	10.93	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	157.10	47.28	12.89	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	129.82	42.84	10.33	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	153.43	60.90	10.83	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	112.19	44.95	9.09	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	124.30	41.65	8.01	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	94.02	29.66	5.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	122.91	60.59	8.66	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	79.31	76.67	26.44	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	149.91	71.96	14.11	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	82.82	62.48	10.90	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	215.40	52.80	19.06	0.70
Hepatocyte, donor1	11523-119I2	15.74	20.58	4.84	0.00
Hepatocyte, donor2	11603-120I1	40.94	17.24	3.23	0.00
Hepatocyte, donor3	11684-122I1	36.20	19.02	6.14	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	145.55	116.83	19.58	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	103.47	66.24	8.04	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	153.40	46.24	11.39	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	423.46	63.68	6.37	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	233.64	73.43	20.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	108.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	278.26	53.99	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	200.21	67.57	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	296.71	94.95	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	233.22	64.07	15.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	242.25	50.28	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	170.55	53.60	6.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	308.45	63.36	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	188.79	50.83	7.26	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	157.49	75.44	10.59	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	353.66	45.45	13.30	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	214.77	57.62	20.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	214.15	65.51	10.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	307.78	57.23	9.28	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	43.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	227.41	74.94	7.11	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	293.01	64.40	9.66	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	59.74	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	214.31	70.08	6.52	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	255.24	72.63	12.59	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	14.37	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	212.98	49.02	9.64	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	311.15	53.55	12.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	232.71	79.77	11.80	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	308.37	43.54	15.42	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	14.74	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	236.75	37.66	10.76	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	313.80	69.88	12.70	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	191.94	54.20	5.10	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	304.38	56.50	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	31.61	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	164.95	51.41	7.85	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	301.97	39.82	19.91	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	246.62	73.46	10.49	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	289.74	38.63	7.02	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	176.02	47.15	15.72	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	214.87	65.37	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	307.62	42.05	8.85	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	226.94	35.66	12.97	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	192.70	48.83	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	317.22	49.50	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	181.20	34.85	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	165.35	69.34	10.67	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	293.71	51.26	8.31	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	193.77	51.29	11.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	207.10	60.75	9.20	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	214.80	33.28	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	173.84	55.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	93.05	44.41	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	103.14	37.29	13.06	0.65
Keratinocyte - epidermal, donor2	11349-117G8	115.37	26.94	8.78	0.00
Keratinocyte - epidermal, donor3	11421-118F8	165.84	46.76	8.90	0.47
Keratinocyte - oral, donor1	11251-116E9	169.03	85.48	11.92	0.23
Keratocytes, donor1	11527-119I6	334.20	153.69	26.13	0.00
Keratocytes, donor2	11607-120I5	142.96	49.22	9.37	0.00
Keratocytes, donor3	11688-122I5	89.71	48.02	5.14	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	17.58	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	148.87	60.41	12.94	0.00
Lens Epithelial Cells, donor2	11609-120I7	80.50	86.38	6.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	112.82	48.64	10.60	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	95.45	81.11	9.96	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	52.19	75.63	8.37	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	70.84	76.50	10.55	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	65.06	61.30	8.07	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	60.83	69.65	4.73	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	73.74	78.60	10.13	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	55.81	52.12	10.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	57.64	91.27	7.33	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	66.43	80.09	8.87	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	55.37	54.98	7.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	67.86	86.08	7.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	63.51	81.28	10.00	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	74.91	54.70	10.45	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	62.97	76.80	8.83	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	62.63	77.05	8.52	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	67.75	65.60	8.93	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	65.15	96.02	6.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	72.65	85.09	11.89	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	68.13	56.28	8.56	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	53.89	82.30	8.49	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	62.73	92.60	9.96	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	63.05	64.02	7.76	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	58.98	75.13	8.35	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	59.34	80.68	11.05	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	64.80	68.95	7.26	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	60.51	71.40	7.33	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	63.91	77.74	9.02	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	79.11	52.28	8.25	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	67.92	80.34	7.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	67.54	76.13	9.33	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	48.46	52.82	7.75	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	50.61	78.07	5.29	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	64.92	73.10	9.79	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	57.75	63.68	10.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	49.17	73.38	5.19	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	65.03	76.86	7.29	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	61.75	58.54	8.68	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	53.87	87.34	3.96	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	66.76	73.06	8.40	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	63.29	57.25	9.24	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	38.78	85.32	5.82	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	66.76	91.34	9.18	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	80.57	64.82	15.04	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	50.63	68.93	6.86	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	60.97	82.63	10.59	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	90.71	69.42	7.05	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	46.87	75.30	5.63	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	82.94	55.49	5.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	190.34	22.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	176.44	121.97	17.64	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	125.44	103.17	10.39	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	76.59	145.98	14.81	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	151.92	135.04	11.96	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	144.76	103.67	14.01	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	58.23	127.27	13.91	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	116.57	91.59	13.08	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	121.24	192.49	15.83	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	98.88	164.90	12.51	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	149.91	132.80	12.15	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	131.69	197.00	14.23	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	83.19	131.98	9.24	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	171.49	134.44	8.12	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	131.26	122.60	15.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	84.56	144.16	7.64	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	169.96	157.42	17.08	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	102.41	177.99	15.49	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	82.22	134.37	11.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	171.24	124.76	10.60	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	112.24	175.76	11.66	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	92.49	159.47	12.61	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	150.43	117.46	13.39	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	133.54	173.31	11.90	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	100.44	172.18	13.15	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	154.91	126.14	15.49	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	90.49	141.04	10.25	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	98.46	147.88	12.17	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	154.27	115.13	8.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	113.97	155.04	14.20	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	74.73	144.93	8.49	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	169.84	101.74	22.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	93.09	155.00	10.39	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	96.95	155.84	12.93	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	193.45	118.76	11.95	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	85.47	147.89	9.29	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	125.78	147.32	13.78	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	153.28	100.19	15.41	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	97.62	153.93	14.66	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	106.79	117.65	11.46	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	150.73	118.03	11.38	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	119.96	140.92	13.40	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	93.93	137.94	9.66	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	170.36	117.16	12.12	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	112.97	157.79	12.96	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	115.13	211.65	17.44	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	153.37	108.95	8.46	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	113.64	162.46	10.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	85.77	123.57	6.54	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	153.30	143.34	12.26	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	88.30	151.93	13.32	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	67.75	120.44	13.17	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	152.35	150.85	13.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	82.46	133.84	12.17	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	61.96	103.27	10.33	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	132.71	110.89	10.24	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	80.94	152.11	12.90	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	87.74	136.57	12.53	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	162.42	128.69	12.45	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	80.95	137.83	7.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	111.82	149.28	16.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	132.49	123.66	10.16	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	114.17	150.81	8.87	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	102.28	137.22	9.11	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	136.02	130.25	11.05	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	85.47	150.67	10.34	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	86.28	106.94	13.98	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	204.74	70.55	10.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	117.04	150.86	14.06	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	101.73	120.84	12.91	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	191.07	76.79	8.47	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	109.96	149.89	10.77	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	86.36	124.74	12.26	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	211.48	68.96	9.77	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	102.85	140.90	9.77	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	94.08	120.96	14.85	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	181.60	83.99	10.21	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	99.85	135.62	11.65	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	82.22	150.34	18.01	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	190.40	73.91	15.45	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	105.47	138.46	13.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	93.00	110.39	16.73	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	191.94	89.29	11.76	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	100.22	155.98	14.55	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	111.05	112.88	16.52	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	223.17	52.46	14.23	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	151.59	140.19	8.55	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	118.10	125.77	19.94	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	230.91	79.89	13.13	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	130.07	123.39	9.80	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	167.93	178.07	20.28	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	262.59	83.55	21.22	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	172.52	174.60	16.63	0.00
Macrophage - monocyte derived, donor1	11232-116C8	48.09	31.68	4.10	0.23
Macrophage - monocyte derived, donor2	11313-117C8	65.15	18.90	4.77	0.18
Macrophage - monocyte derived, donor3	11389-118C3	61.61	23.46	3.80	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	152.93	52.57	19.65	0.53
Mallassez-derived cells, donor2	11929-125I3	102.20	29.47	14.89	0.16
Mallassez-derived cells, donor3	11930-125I4	186.94	44.34	15.84	0.42
Mammary Epithelial Cell, donor1	11273-116H4	163.81	79.02	11.96	0.00
Mammary Epithelial Cell, donor2	11350-117G9	172.57	56.46	13.03	0.00
Mammary Epithelial Cell, donor3	11422-118F9	132.20	39.91	5.74	0.00
Mast cell - stimulated, donor1	11487-119E2	34.57	46.10	5.42	0.00
Mast cell, donor1	11563-120D6	47.15	55.91	3.46	0.32
Mast cell, donor2	11565-120D8	33.88	79.35	2.67	1.49
Mast cell, donor3	11566-120D9	47.05	114.36	2.93	4.95
Mast cell, donor4	11567-120E1	33.68	86.16	1.60	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	76.96	53.67	5.66	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	35.60	81.72	5.84	1.75
Mast cell, expanded, donor5	11939-126A4	71.01	62.64	3.90	0.46
Mast cell, expanded, donor8	11941-126A6	26.44	54.06	2.34	0.50
Melanocyte - dark, donor1	11502-119F8	129.75	102.98	14.23	0.10
Melanocyte - dark, donor2	11582-120F7	116.28	52.60	8.31	0.00
Melanocyte - dark, donor3	11663-122F7	134.23	48.46	9.34	0.22
Melanocyte - light, donor1	11274-116H5	42.08	20.22	2.35	0.00
Melanocyte - light, donor2	11351-117H1	43.00	21.16	5.46	0.68
Melanocyte - light, donor3	11423-118G1	42.49	24.28	5.20	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	112.35	34.36	8.23	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	94.67	53.79	5.65	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	62.95	29.46	6.70	0.00
Meningeal Cells, donor1	11493-119E8	217.72	48.01	13.03	0.37
Meningeal Cells, donor2	11573-120E7	214.35	48.42	9.68	0.00
Meningeal Cells, donor3	11654-122E7	203.18	86.39	17.77	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	204.46	82.41	11.12	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	59.27	39.75	6.84	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	51.25	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	139.97	69.33	11.77	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	142.80	57.41	25.12	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	62.26	39.60	3.18	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	51.77	33.17	5.03	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	270.74	83.95	18.24	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	176.80	56.99	16.80	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	187.62	58.93	14.53	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	75.90	41.69	5.82	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	70.63	57.62	7.43	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.73	93.55	6.18	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.20	59.64	5.93	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	46.71	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	187.00	60.84	11.53	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	281.07	88.97	23.39	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	83.18	89.75	7.82	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	347.61	69.67	16.69	0.00
Mesothelial Cells, donor1	11247-116E5	93.34	27.05	13.52	0.00
Mesothelial Cells, donor2	12156-128G5	63.56	30.53	12.51	0.00
Mesothelial Cells, donor3	11402-118D7	52.97	22.26	6.50	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	36.94	16.99	2.46	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.92	16.20	2.94	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	40.29	14.26	1.24	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.85	14.94	1.66	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	50.05	26.53	2.50	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.27	12.10	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	47.15	19.10	2.03	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.89	17.42	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	45.13	18.58	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	51.67	25.84	2.28	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.53	23.98	1.70	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	16.99	0.89	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.38	24.09	3.26	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.47	12.12	2.14	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	3.87	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	35.00	19.57	2.07	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	32.18	13.88	1.68	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	28.94	12.43	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.26	19.95	3.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.56	6.89	1.56	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.22	17.08	1.10	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	7.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.57	8.97	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.35	10.00	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	2.18	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	40.37	21.14	1.44	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.82	11.61	2.80	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	37.04	25.53	4.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	31.53	17.08	1.31	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	2.21	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	42.39	19.34	2.73	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	2.09	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	45.13	12.31	2.39	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	1.75	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.75	3.91	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	49.10	17.39	1.96	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.87	2.49	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.96	17.80	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.73	5.43	2.50	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	23.90	7.40	2.28	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.24	7.19	0.83	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	41.46	12.96	2.59	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.17	6.01	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	3.18	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.21	8.81	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.33	7.48	1.80	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.55	8.19	1.13	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.13	14.65	4.46	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.25	9.51	2.43	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	3.79	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	36.65	13.64	3.69	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	53.59	9.83	1.47	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	3.91	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.58	9.11	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	47.00	8.65	2.02	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	17.31	13.19	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.12	10.12	1.19	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	26.37	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	55.25	35.65	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.31	29.57	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	28.40	4.21	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	41.32	24.91	1.98	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	38.18	22.35	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	51.45	38.30	4.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.42	24.24	1.86	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	45.13	24.09	1.81	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	29.47	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.54	23.08	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	32.67	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	43.82	33.67	2.14	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	34.78	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	29.29	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.53	19.40	4.22	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	47.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.07	89.65	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	30.77	66.41	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	36.25	36.25	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	159.88	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	117.45	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	52.28	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	125.49	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	132.06	43.52	15.73	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.42	39.20	4.70	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.72	18.02	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.29	12.94	4.17	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.27	35.37	5.89	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	15.96	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	10.88	5.44	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	49.62	12.86	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	19.67	2.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	43.23	25.10	3.95	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.43	19.46	2.70	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.54	22.07	2.31	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	37.23	35.74	2.98	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.36	37.89	3.52	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.75	25.62	2.72	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.13	19.43	2.12	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	37.00	25.70	2.92	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.64	27.58	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.01	24.61	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	30.19	3.94	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.75	18.70	1.95	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.05	21.34	3.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.10	26.72	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	29.88	5.98	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.17	31.81	3.86	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	31.04	28.63	1.72	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	15.17	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.28	20.72	1.78	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	29.21	19.48	4.23	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.28	22.79	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	30.48	32.19	3.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.66	19.66	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	25.25	3.16	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.57	23.01	2.78	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	27.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.89	35.95	4.92	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.83	15.32	3.26	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	14.38	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	22.16	4.52	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	24.69	4.41	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	24.60	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	23.81	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	11.87	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.60	32.06	2.42	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.00	24.98	5.53	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	21.68	4.74	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	15.33	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	40.24	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.76	13.53	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.90	19.67	1.51	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	22.94	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	21.54	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	15.17	5.06	0.00
Myoblast, donor1	11241-116D8	132.30	45.22	16.90	0.12
Myoblast, donor2	11322-117D8	80.55	51.78	9.21	0.77
Myoblast, donor3	11398-118D3	114.18	44.23	12.61	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	46.11	57.94	4.67	0.15
Natural Killer Cells, donor1	11230-116C6	40.90	203.88	4.00	1.85
Natural Killer Cells, donor2	11311-117C6	23.82	185.46	3.02	2.11
Natural Killer Cells, donor3	11387-118C1	31.47	136.75	1.84	0.00
Neural stem cells, donor1	11275-116H6	64.24	65.69	7.26	0.73
Neural stem cells, donor2	11352-117H2	71.25	82.80	13.48	0.00
Neurons, donor1	11494-119E9	94.45	109.24	9.10	1.14
Neurons, donor2	11574-120E8	100.61	88.07	12.33	0.66
Neurons, donor3	11655-122E8	82.22	88.79	11.51	0.00
Neutrophils, donor1	11233-116C9	13.92	13.92	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	11.60	2.90	0.00
Neutrophils, donor3	11390-118C4	12.22	15.27	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	61.86	86.91	4.87	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	32.89	66.42	2.28	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	119.53	43.32	9.83	0.00
Olfactory epithelial cells, donor1	11933-125I7	38.96	44.46	4.54	0.28
Olfactory epithelial cells, donor2	11934-125I8	59.20	47.91	5.36	0.29
Olfactory epithelial cells, donor3	11935-125I9	53.23	45.17	5.90	0.00
Olfactory epithelial cells, donor4	11936-126A1	45.48	54.25	4.09	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	168.51	52.36	10.83	0.00
Osteoblast - differentiated, donor1	11276-116H7	51.90	44.24	5.32	0.21
Osteoblast - differentiated, donor2	11353-117H3	20.58	27.43	9.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	37.24	46.55	3.10	0.00
Osteoblast, donor1	11277-116H8	246.64	90.10	15.83	0.39
Osteoblast, donor2	11354-117H4	121.50	58.99	14.05	0.00
Osteoblast, donor3	11426-118G4	140.41	51.72	7.11	0.18
Pancreatic stromal cells, donor1	11249-116E7	114.05	78.59	10.87	0.42
Pericytes, donor1	11491-119E6	60.42	43.95	5.23	0.00
Pericytes, donor2	11571-120E5	79.23	40.29	4.53	0.00
Pericytes, donor3	11652-122E5	147.91	80.36	13.22	0.61
Perineurial Cells, donor1	11499-119F5	184.68	72.79	10.28	0.00
Perineurial Cells, donor2	11579-120F4	122.37	67.72	8.10	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.70	131.64	1.59	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.47	110.68	1.47	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.75	89.94	1.16	0.52
Placental Epithelial Cells, donor1	11278-116H9	176.98	69.60	18.65	0.24
Placental Epithelial Cells, donor2	11355-117H5	58.77	55.44	13.31	0.00
Placental Epithelial Cells, donor3	11427-118G5	67.34	50.85	4.71	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	69.62	22.47	7.59	0.00
Preadipocyte - breast, donor1	11467-119B9	48.59	44.83	5.44	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	76.62	29.50	9.14	0.13
Preadipocyte - breast, donor2	11328-117E5	48.86	39.40	5.85	0.00
Preadipocyte - omental, donor1	11468-119C1	55.62	40.28	9.48	0.32
Preadipocyte - omental, donor2	11329-117E6	39.72	37.10	9.60	0.00
Preadipocyte - omental, donor3	11403-118D8	75.92	33.81	7.31	0.14
Preadipocyte - perirenal, donor1	11469-119C2	99.41	21.65	5.91	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	182.12	39.00	15.36	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	226.13	66.94	12.22	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	148.15	62.66	12.77	0.17
Preadipocyte - visceral, donor1	11280-116I2	177.26	69.30	13.88	0.56
Preadipocyte - visceral, donor2	11357-117H7	76.39	43.26	6.44	0.00
Preadipocyte - visceral, donor3	11429-118G7	247.54	29.05	8.78	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	135.92	86.29	14.18	1.06
Prostate Epithelial Cells, donor2	11331-117E8	77.46	24.92	11.78	0.27
Prostate Epithelial Cells, donor3	11404-118D9	60.50	28.90	6.74	0.00
Prostate Stromal Cells, donor1	11254-116F3	191.35	83.60	18.34	0.23
Prostate Stromal Cells, donor2	11332-117E9	145.77	65.62	15.06	0.72
Prostate Stromal Cells, donor3	11405-118E1	57.66	48.49	6.05	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	107.30	66.06	12.41	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	96.69	66.05	9.01	0.00
Renal Epithelial Cells, donor1	11517-119H5	141.01	63.40	10.65	0.00
Renal Epithelial Cells, donor2	11597-120H4	111.68	60.46	11.38	0.00
Renal Epithelial Cells, donor3	11678-122H4	71.04	78.76	8.26	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	129.36	37.45	6.13	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	187.19	38.81	9.16	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	136.54	47.73	12.88	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	36.60	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	146.80	59.86	13.21	0.22
Renal Mesangial Cells, donor2	11598-120H5	80.88	61.44	9.40	0.00
Renal Mesangial Cells, donor3	11679-122H5	75.18	66.02	8.60	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	187.63	78.38	15.57	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	129.46	48.92	8.01	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	127.47	77.52	11.38	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	223.76	84.01	13.74	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	94.08	68.79	9.66	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	123.49	60.72	10.29	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	55.70	84.81	10.29	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.03	59.33	3.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	39.31	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	88.06	74.85	11.56	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	45.24	43.50	4.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	71.25	20.15	4.81	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	88.38	41.11	5.56	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	116.11	65.47	9.70	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	139.92	56.19	8.43	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	108.15	51.28	7.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	89.91	49.23	8.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	95.43	15.33	3.97	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	78.51	41.30	6.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	106.26	53.58	10.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	119.36	19.22	7.89	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	94.65	44.43	8.05	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	105.10	46.02	8.19	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	91.19	7.65	6.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	81.89	35.68	4.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	71.03	55.24	6.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	73.52	16.72	3.72	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.85	37.77	6.81	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	83.07	44.88	8.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	87.36	18.69	5.66	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.11	38.12	5.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	72.12	31.79	9.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	70.01	18.78	6.20	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	81.06	40.10	5.52	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	106.65	46.34	6.98	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	115.58	15.33	8.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	90.67	46.23	5.95	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	97.28	44.90	5.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	136.65	18.66	9.95	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.56	40.48	4.65	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	80.84	38.64	6.06	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	132.03	19.38	8.61	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	60.45	26.06	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	79.24	38.37	7.33	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	134.80	12.04	9.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	57.06	32.51	4.94	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	74.04	37.43	6.40	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	86.07	11.08	3.07	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	109.78	42.17	6.21	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	69.30	26.92	5.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	66.09	27.24	2.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	95.24	58.34	5.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	57.04	35.87	2.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	70.91	26.84	4.52	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	57.99	56.25	5.94	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.21	50.77	3.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	80.16	22.27	6.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	43.81	64.63	5.39	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	77.88	55.98	4.87	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	97.95	16.58	8.74	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	51.80	53.15	7.01	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	54.52	55.71	4.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	63.88	33.89	6.85	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	54.43	68.73	6.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.05	42.67	3.61	0.60
Schwann Cells, donor1	11498-119F4	265.93	55.29	9.97	0.19
Schwann Cells, donor2	11578-120F3	156.51	51.04	17.01	0.00
Schwann Cells, donor3	11659-122F3	117.21	46.45	10.52	0.44
Sebocyte, donor1	11220-116B5	128.73	33.41	8.76	0.00
Sebocyte, donor2	11301-117B5	88.23	36.76	11.49	0.46
Sebocyte, donor3	11378-118B1	82.86	42.87	9.28	0.21
Sertoli Cells, donor1	11255-116F4	132.53	82.83	16.57	0.00
Sertoli Cells, donor2	11333-117F1	48.01	81.91	11.30	0.00
Skeletal Muscle Cells, donor1	11281-116I3	111.29	119.39	12.76	0.09
Skeletal Muscle Cells, donor2	11358-117H8	31.81	48.43	5.78	0.00
Skeletal Muscle Cells, donor3	11430-118G8	273.38	56.85	5.85	0.84
Skeletal Muscle Cells, donor4	11451-119A2	310.42	68.18	15.87	0.31
Skeletal Muscle Cells, donor5	11455-119A6	268.75	59.61	10.55	0.45
Skeletal Muscle Cells, donor6	11459-119B1	332.89	64.79	13.24	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	140.87	119.58	10.33	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	131.13	85.61	7.42	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	244.55	81.85	14.68	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	87.37	97.82	11.29	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	217.13	73.82	10.86	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	103.47	35.50	4.95	0.69
Skin - palm, donor1	10286-104F7	8.06	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	93.70	19.89	10.67	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	57.25	12.27	4.91	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	96.20	27.13	7.92	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	94.11	52.27	11.26	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	61.75	27.43	4.08	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	81.20	47.36	9.94	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	46.99	25.86	4.35	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	142.87	20.98	12.65	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	44.24	14.90	4.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	146.96	54.08	12.34	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	80.88	34.70	7.29	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	176.81	52.77	22.45	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	118.20	46.35	14.68	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	88.07	6.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	144.92	49.24	13.44	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	129.45	51.87	9.31	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	172.71	33.42	16.64	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	117.54	68.37	11.40	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	108.68	60.54	8.86	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	83.57	38.15	10.96	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	212.13	61.65	14.48	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	44.14	34.10	3.35	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	97.24	65.16	7.58	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	79.57	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	155.45	37.67	13.83	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	122.11	70.35	11.21	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	119.67	53.59	10.12	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	156.39	56.47	10.39	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	188.71	57.85	23.36	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	129.35	40.96	23.71	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	158.39	35.56	8.67	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	238.64	84.33	15.70	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	60.00	105.07	6.44	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	86.15	32.10	11.98	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	109.68	31.17	8.87	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	141.29	31.40	8.45	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	372.49	85.31	25.17	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	129.30	35.55	8.26	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	101.68	54.22	9.14	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.54	60.88	2.28	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	161.18	59.25	16.43	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	69.02	58.51	4.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	59.44	34.89	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	105.11	56.27	12.09	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	115.11	43.42	15.15	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	144.47	16.92	8.78	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	92.63	35.69	4.72	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	271.91	73.14	12.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	59.80	3.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	138.02	38.86	13.96	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	182.80	63.48	16.57	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	203.45	41.18	12.03	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	191.73	75.46	11.74	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	174.20	80.35	11.40	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	43.33	24.76	1.90	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	154.38	42.57	14.92	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	108.04	30.71	10.16	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	143.36	75.78	7.02	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.30	35.76	3.50	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	47.87	19.57	6.35	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	67.32	45.01	8.93	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	59.65	42.04	5.03	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	83.47	19.31	7.95	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	122.49	36.63	9.06	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	50.28	40.63	6.60	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	21.56	33.94	2.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	28.84	32.60	4.60	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	32.54	38.96	1.38	0.00
Synoviocyte, donor1	11291-117A4	64.30	61.27	6.90	0.00
Synoviocyte, donor2	11368-117I9	47.44	42.24	3.35	0.00
Synoviocyte, donor3	11440-118H9	43.12	29.49	2.46	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	252.99	70.04	19.65	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	105.05	65.41	11.89	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	116.24	71.78	11.81	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	135.13	50.82	13.19	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	118.67	36.34	6.19	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	161.49	27.49	10.88	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	39.49	50.93	3.20	0.12
Urethra, donor2	10319-105A4	5.40	23.38	1.80	0.00
Urothelial Cells, donor1	11520-119H8	152.49	31.61	12.22	0.53
Urothelial Cells, donor2	11600-120H7	103.75	30.44	8.81	0.00
Urothelial Cells, donor3	11681-122H7	71.51	30.26	7.11	0.00
Urothelial cells, donor0	11216-116B1	98.74	44.80	5.35	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	22.24	44.49	5.34	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	61.47	8.58	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.17	64.34	2.74	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	26.51	96.07	2.41	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.05	104.00	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	31.24	34.36	3.12	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	40.38	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	80.34	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	118.18	64.76	9.25	0.37
Wilms' tumor cell line:HFWT	10597-108E3	40.48	32.56	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	102.79	44.97	5.87	0.28
achilles tendon, donor2	10292-104G4	26.86	28.93	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	183.57	130.28	16.83	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	181.56	150.45	17.88	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	54.13	81.43	4.87	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	229.39	115.65	25.03	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	208.56	107.94	16.30	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	134.50	107.64	11.84	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.67	44.37	1.91	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	174.93	109.72	12.78	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	69.01	78.00	6.13	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	113.77	84.65	8.54	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	245.27	50.23	11.04	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	74.11	89.71	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	182.65	81.10	11.85	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	157.67	62.91	16.83	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	171.84	91.47	11.69	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	60.42	43.22	4.18	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	51.41	50.58	9.87	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.78	26.09	7.67	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	176.23	63.15	14.51	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	164.39	70.67	11.83	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	204.60	73.17	17.33	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	127.63	48.33	12.70	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	140.09	56.70	14.34	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	63.18	39.02	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	167.99	61.77	15.07	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	55.82	66.29	6.98	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	7.50	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	58.64	50.16	4.71	0.00
adipose tissue, adult, pool1	10010-101C1	28.54	55.07	2.02	0.00
adipose, donor1	10184-103D4	94.41	158.92	4.69	2.93
adipose, donor2	10185-103D5	44.20	132.20	4.46	0.41
adipose, donor3	10186-103D6	78.69	90.13	7.08	0.54
adipose, donor4	10187-103D7	101.41	95.34	22.54	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.66	36.61	5.05	0.16
adrenal gland, adult, pool1	10081-102A9	54.57	21.83	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	128.47	109.66	4.40	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	92.54	62.53	4.29	0.00
amniotic membrane cells, donor1	12235-129G3	55.41	49.85	4.87	0.00
amniotic membrane cells, donor2	12236-129G4	70.33	70.66	11.83	0.00
amniotic membrane cells, donor3	12237-129G5	35.94	47.43	3.24	0.00
amygdala - adult, donor10196	10167-103B5	59.29	23.72	8.30	4.74
amygdala, adult, donor10252	10151-102I7	41.77	29.40	3.04	1.62
amygdala, newborn, donor10223	10360-105E9	37.12	34.21	5.49	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	50.30	122.62	6.11	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	337.33	110.53	17.21	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.41	76.16	7.01	0.33
aorta, adult, pool1	10052-101G7	30.20	58.84	1.57	0.39
appendix, adult	10189-103D9	30.27	66.37	3.88	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	103.18	98.02	9.63	0.34
artery, adult	10190-103E1	12.23	67.93	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	81.42	117.49	12.17	0.00
b cell line:RPMI1788	10427-106D4	94.28	147.07	6.99	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	104.04	35.24	15.81	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	161.25	66.29	11.91	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	114.65	80.68	10.71	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	72.70	77.17	3.36	0.56
bladder, adult, pool1	10011-101C2	20.86	98.32	1.41	0.00
blood, adult, pool1	10053-101G8	17.72	90.80	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.10	20.55	4.28	0.00
bone marrow, adult	10192-103E3	29.02	40.49	2.70	0.00
brain, adult, donor1	10084-102B3	56.38	39.98	5.13	1.03
brain, adult, pool1	10012-101C3	65.81	62.25	6.46	0.89
brain, fetal, pool1	10085-102B4	74.80	160.28	10.69	0.00
breast carcinoma cell line:MCF7	10482-107A5	72.35	123.23	7.60	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.06	41.94	3.12	0.00
breast, adult, donor1	10080-102A8	23.99	25.25	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	131.99	36.08	6.22	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	63.08	46.69	2.16	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	136.52	97.15	3.91	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	91.51	46.00	4.36	0.00
carcinoid cell line:NCI-H1770	10703-109H1	63.47	55.48	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	53.71	37.85	2.84	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	132.15	110.60	8.24	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	92.90	106.20	6.39	0.27
caudate nucleus - adult, donor10196	10177-103C6	25.33	16.12	6.91	0.00
caudate nucleus, adult, donor10252	10164-103B2	39.32	36.48	3.85	0.50
caudate nucleus, adult, donor10258	10379-105H1	42.79	42.03	6.11	1.53
caudate nucleus, newborn, donor10223	10354-105E3	35.52	47.98	3.66	1.10
cerebellum - adult, donor10196	10173-103C2	40.79	64.09	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	30.32	64.69	3.20	0.00
cerebellum, adult, pool1	10083-102B2	54.50	104.17	3.10	0.34
cerebellum, newborn, donor10223	10357-105E6	26.57	53.14	4.15	0.83
cerebral meninges, adult	10188-103D8	50.93	50.18	4.54	1.51
cerebrospinal fluid, donor2	10294-104G6	10.96	16.81	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	99.21	61.97	5.18	0.29
cervical cancer cell line:ME-180	10553-107I4	101.92	101.25	11.43	0.00
cervix, adult, pool1	10013-101C4	33.81	111.18	1.89	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	93.22	79.14	19.79	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	14.37	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	178.71	167.52	11.81	0.50
choriocarcinoma cell line:SCH	10785-110H2	212.05	153.89	17.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	95.58	43.64	6.17	0.00
chorionic membrane cells, donor1	12238-129G6	56.98	62.11	6.55	0.00
chorionic membrane cells, donor2	12239-129G7	134.43	41.96	9.25	0.20
chorionic membrane cells, donor3	12240-129G8	48.35	64.29	7.14	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	163.59	63.62	18.18	8.08
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	126.79	71.27	6.15	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	83.84	53.64	4.65	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	189.26	54.44	7.45	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	202.21	68.94	9.43	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	220.10	60.88	10.18	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	383.09	121.61	22.08	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	102.17	71.67	12.77	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	75.89	71.55	7.31	0.00
clear cell carcinoma cell line:TEN	10636-108I6	121.97	111.74	11.28	1.04
colon carcinoma cell line:CACO-2	10513-107D9	190.55	89.87	13.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	125.05	179.02	6.08	0.38
colon, adult, donor1	10082-102B1	38.08	51.17	2.38	1.19
colon, adult, pool1	10014-101C5	31.73	62.63	2.47	0.35
colon, fetal, donor1	10070-101I7	27.81	55.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	73.34	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	500.73	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	105.81	83.29	12.75	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	173.12	82.26	11.32	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	197.42	81.36	12.55	0.14
corpus callosum, adult, pool1	10042-101F6	48.21	71.09	4.64	0.22
cruciate ligament, donor2	10295-104G7	17.02	25.12	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	37.72	0.80	0.00
diencephalon, adult	10193-103E4	46.08	28.08	3.36	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	148.33	180.02	7.81	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	98.22	83.09	10.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.42	59.46	5.54	0.00
ductus deferens, adult	10196-103E7	26.41	45.85	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	51.85	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	69.15	7.36	0.00
dura mater, adult, donor1	10041-101F5	59.05	78.71	3.14	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	141.90	155.45	51.52	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	223.54	138.13	42.56	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	30.21	3.08	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	70.53	53.88	4.24	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	60.82	37.98	6.17	0.31
embryonic pancreas cell line:2C6	10603-108E9	65.67	28.90	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	98.21	61.68	11.73	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	90.07	81.74	8.34	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	123.83	65.45	14.79	0.00
epidermoid carcinoma cell line:A431	10426-106D3	60.47	28.12	3.89	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	113.83	35.97	9.02	0.11
epididymis, adult	10197-103E8	31.82	49.61	3.56	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	88.53	82.50	9.23	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	75.90	37.75	6.29	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	231.04	84.79	21.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	200.97	85.72	16.24	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	293.41	91.98	19.61	0.34
esophagus, adult, pool1	10015-101C6	42.68	65.94	2.97	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	47.84	112.46	5.76	0.13
eye - muscle inferior rectus, donor1	10272-104E2	2.41	14.49	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	16.83	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	10.42	0.00	0.00
eye - muscle superior, donor2	10297-104G9	13.76	10.32	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	36.43	1.46	0.00
eye, fetal, donor1	10054-101G9	38.39	78.05	3.56	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	181.95	61.68	12.31	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	278.26	99.24	17.33	2.61
frontal lobe, adult, pool1	10040-101F4	82.38	82.94	9.29	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	122.20	72.96	9.61	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.85	50.02	4.11	0.18
gall bladder, adult	10198-103E9	29.45	52.63	3.62	0.00
gamma delta positive T cells, donor1	11937-126A2	39.19	158.37	3.76	0.54
gamma delta positive T cells, donor2	11938-126A3	44.45	125.87	3.73	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	117.65	70.97	16.47	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	212.18	57.25	7.74	0.19
gastric cancer cell line:AZ521	10549-107H9	136.25	112.31	14.26	0.00
gastric cancer cell line:GSS	10560-108A2	99.76	212.33	7.32	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	41.35	76.99	9.60	0.23
giant cell carcinoma cell line:LU65	10487-107B1	148.93	46.47	6.88	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	131.56	72.50	5.46	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	69.09	41.15	4.99	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	71.14	41.27	6.86	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	71.34	36.09	6.18	0.00
glioblastoma cell line:T98G	10485-107A8	111.37	83.44	7.95	0.00
glioma cell line:GI-1	10413-106B8	44.52	80.54	6.74	0.29
globus pallidus - adult, donor10196	10175-103C4	23.33	16.04	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	33.20	40.76	1.71	0.00
globus pallidus, adult, donor10258	10367-105F7	26.01	34.23	8.22	0.00
globus pallidus, newborn, donor10223	10364-105F4	34.11	34.11	10.13	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	68.52	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	120.21	185.78	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	177.70	308.37	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.40	31.36	3.20	0.32
hIPS +CCl2, biol_rep1	14383-156B9	274.55	49.13	16.53	0.92
hIPS +CCl2, biol_rep2	14384-156C1	286.25	32.92	19.66	0.46
hIPS +CCl2, biol_rep3	14385-156C2	330.42	34.78	18.68	0.64
hIPS, biol_rep1	14380-156B6	178.22	10.06	28.75	1.44
hIPS, biol_rep2	14381-156B7	333.33	24.69	24.01	0.69
hIPS, biol_rep3	14382-156B8	93.79	11.03	8.83	1.10
hairy cell leukemia cell line:Mo	10712-109I1	106.60	81.89	6.90	0.57
heart - mitral valve, adult	10205-103F7	17.64	34.08	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	17.26	37.13	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	27.48	20.82	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	43.87	35.10	3.06	0.20
heart, adult, diseased, donor1	10051-101G6	20.44	35.77	1.28	0.00
heart, adult, pool1	10016-101C7	26.22	22.31	0.92	0.00
heart, fetal, pool1	10046-101G1	39.53	122.29	2.05	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	47.20	33.01	2.16	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	45.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	150.16	62.87	11.93	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	174.54	66.88	14.08	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	158.96	67.50	14.35	0.20
hepatoma cell line:Li-7	10484-107A7	67.17	32.59	8.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	253.26	89.14	17.89	0.60
hippocampus - adult, donor10196	10169-103B7	65.30	23.66	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	35.11	34.08	2.86	0.61
hippocampus, adult, donor10258	10374-105G5	60.75	8.96	5.98	0.50
hippocampus, newborn, donor10223	10363-105F3	29.26	27.49	6.34	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	482.17	257.57	49.44	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	265.86	199.10	34.36	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	301.37	180.01	34.28	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	96.42	146.04	5.07	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	98.12	176.10	5.42	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	113.12	206.89	7.21	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	66.57	96.34	4.67	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	66.35	134.43	7.11	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	64.65	88.42	9.18	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	133.79	142.08	16.34	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	98.20	122.47	13.18	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	113.11	133.31	14.14	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	282.45	174.48	28.48	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	299.20	122.82	35.37	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	318.55	230.41	40.15	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	79.23	169.15	5.15	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	71.08	126.46	7.41	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	74.96	148.93	6.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	57.65	139.79	3.77	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	72.75	116.41	7.28	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	63.27	141.27	5.01	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	72.34	108.92	10.94	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	85.93	81.58	13.93	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	63.97	83.10	9.27	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	244.23	182.90	29.56	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	286.43	136.94	28.53	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	427.50	207.01	40.01	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	103.16	95.41	7.04	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	94.71	100.09	7.60	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	104.40	142.23	6.66	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	56.37	70.85	9.83	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	54.46	77.71	9.96	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.85	84.40	7.44	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	110.18	74.90	9.97	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	81.78	86.32	20.45	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	79.65	79.98	12.43	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	317.34	142.73	25.36	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	293.69	184.50	37.88	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	286.83	159.03	33.17	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	66.93	109.41	3.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	247.25	201.70	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	126.09	183.34	5.96	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	66.22	93.04	6.02	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	59.71	86.13	6.15	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	60.14	84.34	3.20	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	45.35	82.34	11.93	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	105.36	106.31	10.43	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	72.47	75.70	7.54	0.81
immature langerhans cells, donor1	11904-125F5	47.22	73.37	5.09	2.42
immature langerhans cells, donor2	11905-125F6	49.11	91.10	2.38	0.79
insula, adult, pool1	10039-101F3	92.46	84.13	10.69	1.42
keratoacanthoma cell line:HKA-1	10791-110H8	61.13	33.17	5.20	0.33
kidney, adult, pool1	10017-101C8	46.96	56.47	3.70	0.10
kidney, fetal, pool1	10045-101F9	57.37	102.43	4.10	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	99.27	73.57	11.93	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	38.43	71.19	2.49	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	78.35	66.24	4.04	0.00
left atrium, adult, donor1	10079-102A7	13.08	28.88	0.00	0.00
left ventricle, adult, donor1	10078-102A6	28.82	22.25	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	122.85	43.50	4.38	0.27
leiomyoma cell line:10964C	10569-108B2	63.95	31.25	2.87	0.36
leiomyoma cell line:15242A	10570-108B3	75.00	24.46	6.52	0.54
leiomyoma cell line:15425	10571-108B4	81.10	32.05	6.56	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	57.14	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	30.32	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	170.83	87.48	12.87	0.35
liposarcoma cell line:KMLS-1	10782-110G8	42.49	39.52	5.47	0.31
liposarcoma cell line:SW 872	10726-110A6	80.17	69.69	4.51	0.00
liver, adult, pool1	10018-101C9	80.71	43.76	7.13	0.16
liver, fetal, pool1	10086-102B5	34.81	15.99	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	23.33	33.10	3.50	0.29
locus coeruleus, adult, donor10252	10165-103B3	34.51	39.49	4.43	0.55
locus coeruleus, adult, donor10258	10375-105G6	47.40	34.99	7.05	0.28
locus coeruleus, newborn, donor10223	10362-105F2	45.01	38.28	7.15	1.26
lung adenocarcinoma cell line:A549	10499-107C4	66.01	59.37	5.40	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	49.64	30.33	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	83.84	46.14	2.64	0.00
lung, adult, pool1	10019-101D1	29.53	55.99	2.13	0.00
lung, fetal, donor1	10068-101I5	27.68	50.23	3.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	44.45	46.28	0.92	0.46
lymph node, adult, donor1	10077-102A5	51.60	61.06	3.79	0.00
lymphangiectasia cell line:DS-1	10727-110A7	80.88	81.97	3.73	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	129.50	107.91	6.94	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	32.28	28.03	9.34	0.85
mature adipocyte, donor1	12231-129F8	21.76	34.19	0.89	0.00
mature adipocyte, donor2	12232-129F9	30.09	40.47	1.66	0.21
mature adipocyte, donor3	12233-129G1	32.95	30.11	3.08	0.00
mature adipocyte, donor4	12234-129G2	34.22	54.49	2.63	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	63.62	60.52	5.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	59.79	23.69	7.90	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	34.39	32.18	3.68	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	47.65	21.29	3.49	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	52.46	48.62	7.68	5.97
medial temporal gyrus - adult, donor10196	10183-103D3	58.22	44.38	5.23	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	29.29	26.32	2.97	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	11.56	5.78	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	43.06	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	47.02	52.05	6.82	3.59
medulla oblongata - adult, donor10196	10174-103C3	35.69	16.22	3.24	0.00
medulla oblongata, adult, donor10252	10155-103A2	29.57	31.58	2.17	0.31
medulla oblongata, adult, pool1	10038-101F2	53.87	67.51	6.45	0.65
medulla oblongata, newborn, donor10223	10361-105F1	30.90	35.41	5.55	0.00
medulloblastoma cell line:D283 Med	10838-111E1	93.88	168.05	9.52	0.22
medulloblastoma cell line:ONS-76	10759-110E3	111.39	40.59	5.62	0.24
melanoma cell line:COLO 679	10514-107E1	78.05	58.79	11.79	0.57
melanoma cell line:G-361	10465-106H6	109.94	55.38	7.60	1.09
meningioma cell line:HKBMM	10691-109F7	83.58	45.59	5.43	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	93.40	66.09	13.22	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	109.65	63.77	12.70	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	218.34	72.11	10.74	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	107.80	71.26	6.54	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	152.39	28.16	8.28	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	64.20	37.79	2.95	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	67.59	38.71	6.55	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	45.81	21.52	6.94	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	94.06	42.91	6.18	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	100.29	46.24	6.10	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	154.39	46.16	11.14	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	160.70	43.35	10.26	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	111.11	29.31	6.54	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	34.58	47.10	3.95	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	125.50	41.65	8.58	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	95.65	39.45	5.93	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	103.72	35.73	5.51	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.60	33.79	7.55	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	60.73	35.07	4.24	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	65.43	17.33	10.03	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	207.26	36.08	21.40	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	109.39	39.30	7.47	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	78.51	35.62	5.43	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.98	36.82	2.58	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	52.37	28.33	6.87	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	149.46	82.10	10.53	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	87.22	56.63	5.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	83.39	54.74	8.95	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	71.46	56.02	9.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	76.71	50.83	8.93	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	64.02	52.72	6.12	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	63.63	55.51	5.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	63.27	58.95	7.86	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	62.56	53.75	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	94.89	55.95	9.81	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	65.59	52.43	8.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	68.26	57.20	7.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.80	44.73	6.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	62.43	48.67	6.04	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	57.31	54.45	6.96	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	56.70	51.12	8.16	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	49.22	10.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	41.32	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	73.40	70.48	9.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	53.83	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	74.10	77.30	12.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	58.06	59.70	9.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	58.70	56.75	9.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	65.06	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	50.67	63.58	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	42.90	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	53.96	41.51	6.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	58.49	48.74	9.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	67.14	57.00	8.87	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	45.53	62.08	7.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	62.33	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	55.89	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	30.99	10.33	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	45.23	66.42	5.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.16	62.76	5.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.71	58.36	5.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.87	52.68	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	53.47	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	59.13	52.04	5.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	43.66	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	88.11	53.01	9.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	93.02	53.93	10.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	76.26	42.62	5.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	83.32	51.52	10.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	47.55	12.09	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	100.31	65.42	6.54	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	67.15	34.21	3.80	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	53.41	35.20	10.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	27.11	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	54.36	50.24	7.41	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	57.54	47.03	6.55	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	58.73	39.91	6.81	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	26.48	5.09	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	11.61	13.15	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	116.94	50.08	8.03	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	148.27	51.89	12.97	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	29.92	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	195.64	56.92	29.08	1.44
mesothelioma cell line:Mero-25	10850-111F4	153.42	71.26	15.21	0.23
mesothelioma cell line:Mero-41	10851-111F5	122.97	58.19	9.53	0.00
mesothelioma cell line:Mero-48a	10852-111F6	103.41	50.26	11.29	0.22
mesothelioma cell line:Mero-82	10853-111F7	122.20	46.25	16.82	0.26
mesothelioma cell line:Mero-83	10854-111F8	117.45	39.66	12.09	0.00
mesothelioma cell line:Mero-84	10855-111F9	55.10	30.84	6.57	0.00
mesothelioma cell line:Mero-95	10856-111G1	87.16	52.80	7.04	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	98.06	31.47	9.44	0.00
mesothelioma cell line:NCI-H226	10846-111E9	168.50	96.65	23.71	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	65.08	30.06	5.81	0.00
mesothelioma cell line:NCI-H28	10845-111E8	118.33	81.17	11.45	0.76
mesothelioma cell line:No36	10857-111G2	110.58	38.49	9.46	0.00
mesothelioma cell line:ONE58	10858-111G3	60.15	32.51	7.59	0.00
migratory langerhans cells, donor1	11901-125F2	45.29	53.93	2.11	0.38
migratory langerhans cells, donor2	11902-125F3	37.00	35.17	2.93	0.24
migratory langerhans cells, donor3	11903-125F4	41.28	68.74	3.95	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.75	44.07	10.12	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	135.85	49.59	17.38	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	83.62	41.93	5.53	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	104.66	53.47	4.76	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	202.35	167.05	17.37	1.48
myeloma cell line:PCM6	10474-106I6	71.95	76.50	6.13	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.09	21.31	7.61	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	78.65	57.08	8.04	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	124.35	54.15	9.81	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	126.78	59.94	12.43	0.07
nasal epithelial cells, donor2	12227-129F4	52.44	49.13	7.73	0.00
neuroblastoma cell line:CHP-134	10508-107D4	53.37	214.88	5.98	0.00
neuroblastoma cell line:NB-1	10539-107G8	211.78	175.30	15.34	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	131.38	91.53	11.39	0.00
neuroblastoma cell line:NH-12	10555-107I6	118.71	336.74	6.89	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.16	166.06	2.85	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	67.15	115.93	5.86	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	157.99	181.54	11.87	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	34.33	15.26	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	56.96	32.47	3.19	0.27
neutrophil PMN, donor1	12133-128D9	0.00	89.25	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	142.06	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	106.21	158.80	9.81	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	78.45	99.26	4.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	61.56	45.53	7.05	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	65.95	61.22	5.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	73.12	62.15	8.25	1.12
occipital cortex - adult, donor10196	10172-103C1	45.33	20.60	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	24.96	32.47	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	39.67	49.50	6.91	2.18
occipital lobe, adult, donor1	10076-102A4	63.50	44.87	6.30	1.57
occipital lobe, fetal, donor1	10073-102A1	59.64	115.43	9.01	0.86
occipital pole, adult, pool1	10036-101E9	60.71	64.49	6.07	0.39
olfactory region, adult	10195-103E6	51.58	40.12	4.39	0.38
optic nerve, donor1	10277-104E7	18.01	30.02	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	62.99	70.51	6.04	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	132.58	74.60	5.91	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.99	45.38	5.59	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	129.60	86.28	7.85	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	46.74	33.51	6.47	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	54.19	9.34	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	71.25	69.34	6.57	0.00
ovary, adult, pool1	10020-101D2	30.40	153.56	2.27	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	69.11	34.83	4.58	0.18
pancreas, adult, donor1	10049-101G4	71.49	91.24	5.64	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	93.09	77.99	5.31	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	134.07	86.71	14.99	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.02	29.64	2.32	0.00
paracentral gyrus, adult, pool1	10035-101E8	72.67	68.46	8.42	1.19
parietal cortex, adult, donor10258	10373-105G4	47.71	14.68	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	33.86	16.93	10.35	0.00
parietal lobe, adult, donor10252	10157-103A4	27.36	32.21	4.28	0.29
parietal lobe, adult, pool1	10034-101E7	72.43	58.16	8.28	0.88
parietal lobe, fetal, donor1	10072-101I9	55.28	124.14	3.88	1.94
parietal lobe, newborn, donor10223	10356-105E5	42.99	48.23	3.36	2.99
parotid gland, adult	10199-103F1	62.28	117.78	2.47	0.00
penis, adult	10200-103F2	21.48	71.44	3.22	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	17.48	55.22	2.60	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	83.63	56.82	5.97	0.44
pineal gland - adult, donor10196	10179-103C8	27.09	17.42	3.87	0.00
pineal gland, adult, donor10252	10160-103A7	45.60	63.37	9.48	0.00
pineal gland, adult, donor10258	10377-105G8	51.42	37.62	7.52	0.00
pituitary gland - adult, donor10196	10180-103C9	56.66	24.28	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	65.67	33.36	5.73	0.00
pituitary gland, adult, donor10258	10378-105G9	79.17	44.26	7.66	0.00
placenta, adult, pool1	10021-101D3	50.85	51.49	3.01	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	51.65	47.67	4.77	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.03	35.49	2.18	0.31
pons, adult, pool1	10033-101E6	57.84	56.03	9.21	0.43
postcentral gyrus, adult, pool1	10032-101E5	73.31	68.43	6.97	1.39
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	66.92	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	115.67	313.96	11.02	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	328.60	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	126.00	84.34	7.43	0.15
prostate cancer cell line:PC-3	10439-106E7	143.02	77.68	4.90	0.18
prostate, adult, pool1	10022-101D4	25.76	84.25	2.00	0.09
putamen, adult, donor10196	10176-103C5	57.36	52.64	10.39	0.24
putamen, adult, donor10252	10152-102I8	31.37	31.37	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	100.54	29.51	5.46	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	44.70	32.62	5.32	0.24
putamen, newborn, donor10223	10365-105F5	37.48	53.23	10.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	35.49	59.93	0.87	0.29
rectum, fetal, donor1	10067-101I4	36.17	82.07	8.35	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	37.74	22.26	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.63	34.79	0.00	0.00
retina, adult, pool1	10030-101E3	42.24	76.44	2.98	0.10
retinoblastoma cell line:Y79	10475-106I7	131.46	228.63	11.17	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	130.57	64.42	9.34	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	80.42	84.08	7.03	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	10.61	33.35	3.79	0.00
salivary acinar cells, donor1	11771-123I7	28.97	34.96	2.91	0.16
salivary acinar cells, donor2	11772-123I8	26.44	63.06	2.75	0.14
salivary acinar cells, donor3	11773-123I9	8.61	20.52	2.65	0.00
salivary gland, adult, pool1	10093-102C3	59.48	70.92	4.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	88.02	71.75	6.74	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	101.33	71.94	6.11	0.12
seminal vesicle, adult	10201-103F3	31.22	53.97	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	142.84	104.70	23.32	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.69	23.91	2.52	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	63.22	27.10	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	43.92	93.35	7.79	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	86.10	82.01	7.96	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	160.38	81.67	7.61	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	23.41	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	45.34	90.79	2.04	0.00
skeletal muscle, fetal, donor1	10066-101I3	27.14	79.40	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	61.07	0.00	0.00
skin, fetal, donor1	10065-101I2	35.98	59.34	2.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	186.77	78.38	15.68	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	77.86	118.20	18.91	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	135.69	135.12	9.83	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	99.39	125.76	8.24	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.34	136.88	3.38	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.50	57.97	4.36	0.65
small intestine, adult, pool1	10024-101D6	43.48	61.15	2.15	0.24
small intestine, fetal, donor1	10064-101I1	49.38	93.12	2.70	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.98	47.19	4.62	1.03
smooth muscle, adult, pool1	10048-101G3	24.81	74.95	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	28.41	36.18	1.61	0.54
spinal cord - adult, donor10196	10181-103D1	27.76	37.39	2.98	0.46
spinal cord, adult, donor10252	10159-103A6	22.08	33.12	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	65.03	8.30	5.53	0.00
spinal cord, fetal, donor1	10056-101H2	54.28	57.93	6.71	0.00
spinal cord, newborn, donor10223	10359-105E8	33.06	36.74	5.05	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	73.33	27.78	4.03	0.00
spleen, adult, pool1	10025-101D7	43.94	60.46	2.75	0.11
spleen, fetal, pool1	10044-101F8	47.20	62.93	4.29	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	93.16	80.84	6.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	83.93	44.81	3.61	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	47.87	39.14	10.13	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	68.80	50.04	10.16	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	102.99	39.73	11.71	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	108.02	62.69	7.62	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	97.73	38.92	9.73	0.42
stomach, fetal, donor1	10062-101H8	48.06	79.03	2.14	0.00
submaxillary gland, adult	10202-103F4	30.19	79.76	3.99	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	24.72	40.50	2.28	0.00
substantia nigra, adult, donor10258	10371-105G2	62.07	8.79	4.14	0.00
substantia nigra, newborn, donor10223	10358-105E7	19.78	28.26	4.95	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	89.64	59.38	7.80	0.23
temporal lobe, adult, pool1	10031-101E4	72.22	59.34	9.07	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	118.24	6.41	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	46.59	109.44	7.03	0.44
tenocyte, donor1	11763-123H8	77.85	43.29	9.43	0.35
tenocyte, donor2	11765-123I1	46.16	38.53	6.87	0.00
tenocyte, donor3	11768-123I4	80.06	34.10	8.15	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	261.40	87.36	23.11	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	216.58	130.56	17.26	0.92
teratocarcinoma cell line:PA-1	10807-111A6	168.00	74.08	11.78	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	138.88	61.32	16.63	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	89.63	104.00	8.32	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	84.52	40.79	5.02	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	99.01	66.12	9.45	0.65
testis, adult, pool1	10026-101D8	93.63	87.40	3.76	62.71
testis, adult, pool2	10096-102C6	149.31	108.26	5.86	112.32
thalamus - adult, donor10196	10168-103B6	22.08	19.87	1.10	0.00
thalamus, adult, donor10252	10154-103A1	26.57	33.60	2.50	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	16.94	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.28	27.17	4.61	0.00
thalamus, newborn, donor10223	10366-105F6	31.64	26.46	6.33	6.90
throat, adult	10209-103G2	31.46	56.43	3.99	0.25
throat, fetal, donor1	10061-101H7	34.13	63.99	3.05	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	132.36	151.83	13.91	0.00
thymus, adult, pool1	10027-101D9	45.63	103.79	4.18	0.50
thymus, fetal, pool1	10043-101F7	48.94	77.82	4.36	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	90.41	44.67	8.91	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	256.75	124.74	12.99	0.14
thyroid, adult, pool1	10028-101E1	61.96	107.03	4.20	0.00
thyroid, fetal, donor1	10060-101H6	36.39	49.83	3.16	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	40.04	0.00	0.00
tongue, adult	10203-103F5	46.28	53.26	3.72	0.23
tongue, fetal, donor1	10059-101H5	42.17	48.47	3.55	0.00
tonsil, adult, pool1	10047-101G2	70.22	103.98	3.91	0.10
trachea, adult, pool1	10029-101E2	56.52	51.37	4.17	0.41
trachea, fetal, donor1	10058-101H4	48.47	55.78	4.62	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	96.36	41.80	4.96	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	48.13	46.71	4.86	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	160.60	153.08	9.56	0.16
tridermal teratoma cell line:HGRT	10694-109G1	15.22	20.93	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	69.92	54.43	4.32	0.25
umbilical cord, fetal, donor1	10057-101H3	18.78	31.30	6.26	0.00
uterus, adult, pool1	10100-102D1	40.78	55.62	2.90	0.00
uterus, fetal, donor1	10055-101H1	36.35	63.99	0.51	0.00
vagina, adult	10204-103F6	10.34	42.65	1.29	0.00
vein, adult	10191-103E2	23.45	71.02	3.29	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	126.84	106.28	6.68	0.00